Low-dose metronomic cyclophosphamide complements the actions of an intratumoral C-class...

(Impact Journals LLC) Intratumoral injection of SD-101 induces significant anti-tumor immunity in preclinical and clinical studies, especially when combined with PD-1 blockade.